Literature DB >> 1592070

Prognosis after therapy discontinuation in children with epilepsy.

C Mastropaolo1, M Tondi, F Carboni, S Manca, F Zoroddu.   

Abstract

Anticonvulsant therapy was stopped in 191 epileptic children (109 males and 82 females) after a seizure-free period of at least 2 years, independent of EEG findings, followed up for a minimum of 2 years after withdrawal. Overall, 43 (22.5%) had recurrence of seizures; of these, 79% relapsed within the 1st year after drug stopping and 93% within the 2nd year. The probability of remaining seizure free was 97% at the end of the withdrawal period, 82% 1 year later, 79% at 2 years and 77% at 5 years. In order to evaluate the risk of recurrence and the predictive factors of relapse, several parameters were investigated by univariate and multivariate statistical analysis. At univariate analysis, the factors which proved to be significantly correlated to relapses were: age at onset over 4 years, seizure-free time less than 2 years, sudden drug discontinuation, pathological EEG records during seizure-free time and paroxysmal responses to intermittent photic stimulation (IPS). At multivariate analysis, only age at onset, seizure-free time and sudden discontinuation were the factors indicating a significantly higher relapse risk; paroxysmal IPS responses, when analyzed in association with these variables, proved to be significant and increased the predictive value for prognosis of associated factors.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1592070     DOI: 10.1159/000116811

Source DB:  PubMed          Journal:  Eur Neurol        ISSN: 0014-3022            Impact factor:   1.710


  5 in total

1.  Rapid versus slow withdrawal of antiepileptic monotherapy in two-year seizure-free adults patients with epilepsy (RASLOW) study: A pragmatic multicentre, prospective, randomized, controlled study.

Authors:  Edoardo Ferlazzo; Giorgia Giussani; Sara Gasparini; Elisa Bianchi; Vittoria Cianci; Vincenzo Belcastro; Roberto Cantello; Gionata Strigaro; Matilde Lazzari; Amedeo Bianchi; Martina Guadagni; Silvia Pradella; Angela La Neve; Teresa Francavilla; Nicola Pilolli; Paola Banfi; Francesco Turco; Marta Piccioli; Luigi Polidori; Teresa Anna Cantisani; Rossella Papetti; Michela Cecconi; Elisabetta Pupillo; Emilio Davide Arippol; Gabriele Enia; Sabrina Neri; Umberto Aguglia; Ettore Beghi
Journal:  Neurol Sci       Date:  2022-06-01       Impact factor: 3.830

2.  Discontinuation of anti-epileptic therapy: a retrospective study of 86 children and adolescents.

Authors:  A Matricardi; F Bertamino; D Risso
Journal:  Ital J Neurol Sci       Date:  1995-12

3.  Factors predicting the risk of relapse after antiepileptic drug discontinuation in children with partial seizures.

Authors:  F Donati; R I Hassink; H Jung; F Vassella
Journal:  Eur J Pediatr       Date:  1995       Impact factor: 3.183

Review 4.  Should antiepileptic drugs be withdrawn in seizure-free patients?

Authors:  Luigi M Specchio; Ettore Beghi
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

5.  Rapid versus slow withdrawal of antiepileptic monotherapy in 2-year seizure-free adult patients with epilepsy (RASLOW) study: a pragmatic multicentre, prospective, randomized, controlled study.

Authors:  Sara Gasparini; Edoardo Ferlazzo; Giorgia Giussani; Domenico Italiano; Vittoria Cianci; Chiara Sueri; Edoardo Spina; Ettore Beghi; Umberto Aguglia
Journal:  Neurol Sci       Date:  2016-01-25       Impact factor: 3.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.